Abbott and Abbott Fund launch 'Future Well Kids' program to help students shape healthier lives

AbbottAbbott and its foundation, the Abbott Fund, launched Future Wellâ„¢ Kids, a program designed to educate and inspire middle school students ages 10-13 to learn about the causes of chronic disease and adopt healthy habits to live healthier, fuller lives.

Chronic diseases, also known as noncommunicable diseases (NCDs) such as diabetes and cardiovascular disease, are the leading cause of death around the world. According to the World Health Organization (WHO), NCDs are estimated to account for 71% of all deaths globally and 88% of all deaths in the U.S. The conditions and behaviors that lead to NCDs often start in childhood - globally, 81% of adolescents don't get enough physical activity, and in the U.S., 32% of children and adolescents are overweight or obese.

Through Future Well Kids, Abbott employee volunteers bring their health expertise to the classroom, working with teachers in local communities. The Abbott Fund partnered with Discovery Education, the global leader in standards-aligned digital curriculum resources, engaging content and professional learning for K-12 classrooms, to develop a fun and compelling curriculum.

"Middle school is a critical time, as students are becoming more independent and making their own choices about food and physical activity," said Molly Schaefer, principal at Thomas Jefferson Middle School in Waukegan, Ill., which is participating in the Future Well Kids program. "The Future Well Kids program brings forward practical, hands-on ideas that students can use to begin establishing good habits and patterns now, which will set themselves up for a happy, healthy future."

Through classroom activities and digital lessons, students learn about good nutrition and physical fitness, and why these behaviors are so important to their health and wellbeing. And because developing healthy habits requires action, the program focuses on empowering students to take charge of their health by making simple changes in their own lives - such as creating nutritious meal plans, setting fitness goals, and learning how to differentiate between sound nutrition advice and online health fads.

"We created the Future Well Kids program to educate and empower students to develop healthy habits today, so they can reduce their risk of developing chronic diseases such as Type 2 diabetes and heart disease during their lifetime," said Jenna Daugherty, divisional vice president of global citizenship and sustainability at Abbott, and vice president of the Abbott Fund. "It's also a great way for Abbott employees to share their expertise and passion for health, working side-by-side with their neighbors to have a meaningful impact in local communities."

The Future Well Kids program serves schools that are in underserved communities near Abbott sites in California, Florida, Illinois, Michigan, Minnesota, Ohio, Texas and Virginia, as well as Ireland and Mexico. The program builds on Abbott's extensive expertise in nutrition, cardiovascular disease and diabetes care, and is designed to empower kids, support teachers and engage Abbott employees.

About Future Well

Chronic diseases - also called noncommunicable diseases, or NCDs, such as diabetes and cardiovascular disease - are among the greatest health threats of our time. These complex health challenges affect every family and every community. That's why we're working to find new answers, through our life-changing technologies, across our businesses and in partnership with others through Future Well initiatives.

Working in close collaboration with leading organizations and communities, Abbott and the Abbott Fund's Future Well initiatives are focused on finding new ways to outsmart the drivers of chronic diseases. From school-based outreach to help young people make healthier choices, to partnerships that empower communities to address social and economic barriers to good health, Future Well programs are testing new ideas to help build a healthier future.

About Abbott and the Abbott Fund

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

The Abbott Fund is a philanthropic foundation established by Abbott in 1951. The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to healthcare and strengthen communities worldwide.

Most Popular Now

OPKO and Pfizer announce positive Phase 3 top-line…

OPKO Health Inc. (NASDAQ: OPK) and Pfizer Inc. (NYSE: PFE) announced that the global Phase 3 trial evaluating somatrogon dosed once-weekly in pre-pubertal children with g...

Amgen recommends rejection of 'mini-tender' offer …

Amgen (NASDAQ:AMGN) today announced that it has been notified of an unsolicited "mini-tender" offer dated Oct. 11, 2019, made by TRC Capital Corporation, a private Canadi...

Researchers find new signaling systems in human ce…

The human cell has a wide variety of receptors on its surface that many molecules and therapeutic drugs can bind to in order to activate signals inside the cell to regula...

Rare diseases: Over 300 million patients affected …

Rare diseases represent a global problem. Until now, the lack of data made it difficult to estimate their prevalence. Created and coordinated by Inserm, the Orphanet data...

Bed time is the best time to take blood pressure m…

People with high blood pressure who take all their anti-hypertensive medication in one go at bedtime have better controlled blood pressure and a significantly lower risk ...

One avocado a day helps lower 'bad' cholesterol fo…

Move over, apples - new research from Penn State suggests that eating one avocado a day may help keep "bad cholesterol" at bay. According to the researchers, bad choleste...

Boehringer Ingelheim advances first pan-KRAS inhib…

Boehringer Ingelheim presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Con...

Rare diseases: Over 300 million patients affected …

Rare diseases represent a global problem. Until now, the lack of data made it difficult to estimate their prevalence. Created and coordinated by Inserm, the Orphanet data...

Synthetic phages with programmable specificity

Bacteriophages ("phages" for short) are viruses that infect bacteria. Phages are highly host-specific and will typically only infect and kill an individual species or eve...

Cannabis could help alleviate depression and suici…

Cannabis may be helping Canadians cope with the effects of post-traumatic stress disorder (PTSD), new research suggests. In an analysis of health survey data collected by...

AstraZeneca divests rights to Seroquel and Seroque…

AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended rel...

Attacking metastatic breast cancer with sound

Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. Tohoku University researchers tested...